Double whammy: increased severe primary graft dysfunction after prolonged warm ischemia and inadequate oxygen delivery during heart transplant

双重打击:心脏移植过程中长时间热缺血导致严重原发性移植物功能障碍加重,以及氧气输送不足。

阅读:1

Abstract

OBJECTIVE: This exploratory study examined the relationship between oxygen delivery index (DO2i) during DCD heart transplant (HT), warm ischemic time, and posttransplant outcomes. METHODS: All DCD HT between 10/2021 and 12/2024 using normothermic regional perfusion (NRP) at our institution were included. Multiorgan transplants and congenital heart disease patients were excluded. Critical areas-sum of magnitude and duration of DO2i under specific thresholds-were calculated for thresholds 300, 280, and 260 mL/min/m2. Receiver operating characteristics (ROC) analysis dichotomized the critical area into high area (low DO2i) and low area (high DO2i) groups. Patients were then stratified into 4 groups based on high/low functional warm ischemic time (FWIT), and high/low DO2i. Outcomes were compared across groups. RESULTS: The critical area under 260 mL/min/m2 was the best predictor of severe primary graft dysfunction (PGD). 102 patients met inclusion criteria, and were stratified into four groups based on FWIT above/below 23 min and critical area below/above 1,424 mL/m2 (identified by ROC analysis). 39 (38.2%) patients had low FWIT/ high DO2i, 18 (17.6%) had low FWIT/ low DO2i, 24 (23.5%) had high FWIT/high DO2i, and 21 (20.6%) had high FWIT/low DO2i. Rates of severe PGD were greater in the high FWIT/low DO2i group compared to the low FWIT/high DO2i group (23.8% vs. 0%, p = 0.004). Rates of 30-day mortality were higher in the high FWIT/low DO2i group compared to the low FWIT/high DO2i group (14.3% vs. 0%, p = 0.039). CONCLUSIONS: Higher oxygen delivery during HT was associated with improved short-term outcomes, and may counteract the myocardial damage from warm ischemia during DCD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。